Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

28.8K
Overview
28.8K
Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Active versus Passive Immunity01:31

Active versus Passive Immunity

8.7K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
8.7K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccines01:21

Vaccines

105
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
105

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach.

medRxiv : the preprint server for health sciences·2026
Same author

Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.

medRxiv : the preprint server for health sciences·2026
Same author

Spatio-temporal spread of COVID-19 over three variant waves in the continental United States.

Proceedings. Biological sciences·2026
Same author

Infectious disease outbreak controllability: biological, social and public health factors.

Proceedings. Biological sciences·2026
Same author

Reconstructing the early spatial spread of pandemic respiratory viruses in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Research Priorities for Zoonotic and Pandemic Influenza Vaccines: Evidence and Recommendations from the WHO Public Health Research Agenda for Influenza (2024 Update).

Vaccines·2025
Same journal

Precision oncology's translation gap-Can molecular tumor boards bridge it?

PLoS medicine·2026
Same journal

Improving suicide prevention in men.

PLoS medicine·2026
Same journal

Multilevel onsite training and mentorship model to accelerate early childhood cancer diagnosis in Northwest Ethiopia: A quasi-experimental mixed method study.

PLoS medicine·2026
Same journal

The well-worn path from armed conflict to measles resurgence.

PLoS medicine·2026
Same journal

Association of armed conflict and global measles cases: A structural equation modeling analysis of 193 countries from 2000 to 2023.

PLoS medicine·2026
Same journal

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.

PLoS medicine·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

18.5K

Vaccinating to protect a vulnerable subpopulation.

Jonathan Dushoff1, Joshua B Plotkin, Cecile Viboud

  • 1Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey, United States of America. dushoff@eno.princeton.edu

Plos Medicine
|May 24, 2007
PubMed
Summary
This summary is machine-generated.

Optimizing influenza vaccination is complex. Shifting vaccines to highly transmissive groups can protect vulnerable populations, but requires careful consideration of mixing patterns and disease transmission levels to avoid unintended increases in illness.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.2K

Related Experiment Videos

Last Updated: May 7, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

18.5K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.2K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Influenza epidemics cause significant mortality and morbidity, particularly in winter.
  • Schoolchildren are key spreaders of influenza, while the elderly and very young are most vulnerable.
  • Optimal population protection strategies are unclear when transmission and vulnerability are unevenly distributed.

Purpose of the Study:

  • To investigate optimal vaccination strategies for epidemic influenza.
  • To determine how to best protect a population with distinct disease-spreading and vulnerable groups.
  • To analyze the impact of vaccine allocation on disease spread and impact.

Main Methods:

  • Developed a mathematical model of epidemic influenza.
  • Incorporated assortative mixing patterns between host groups.
  • Evaluated various vaccine allocation strategies across diverse parameter values.

Main Results:

  • Optimal vaccination strategy is highly sensitive to population mixing (assortativity) and disease reproductive number.
  • Small parameter changes can shift optimal strategy from protecting vulnerable to targeting transmissive groups.
  • Vaccine allocation effectiveness depends critically on disease transmission dynamics and social mixing.

Conclusions:

  • Changes to vaccination strategy require caution due to parameter uncertainty.
  • Shifting vaccines to more active groups may protect vulnerable populations, but risks are present.
  • Increased disease in vulnerable groups can occur with excessive vaccine shifts, stringent limitations, high transmission, or structured mixing.